alzheimers-disease

New blood marker can identify Parkinsonian diseases

Is it possible that a single biomarker can detect all types of diseases related to dopamine deficiency in the brain? Yes, that's what a research group is discovering. 'We have observed that an enzyme in cerebrospinal fluid and in blood is a useful marker for identifying all types of Parkinson's-rela...
Read More

Telecare cuts costs, boosts quality of life for dementia patients

A telecare program that improves outcomes for patients with dementia and lightens the load for unpaid caregivers also has the surprising bonus of cutting Medicare costs, according to new research.

Could a breakdown in the brain's networks allow infections to contribute to Alzheimer's disease?

New data gives more evidence to the possibility that developing a pathobiome in the brain could cause some forms of Alzheimer's and related dementias.

Large amounts of sedentary time linked with higher risk of dementia in older adults, study shows

Researchers have used machine learning to explore the links between sedentary behavior and dementia, finding that the total time spent sedentary matters for brain aging.

New window on leading genetic cause of Alzheimer's

Scientists have opened a new view into the workings of the brain and central nervous system, detecting a diverse set of important molecules known as lipoproteins. The most common protein on the particles is apolipoprotein E; one form of APOE puts people at higher risk of Alzheimer's disease....
Read More

AI tool helps optimize antibody medicines

Antibody treatments may be able to activate the immune system to fight diseases like Parkinson's, Alzheimer's and colorectal cancer, but they are less effective when they bind with themselves and other molecules that aren't markers of disease.

Exercise-induced hormone irisin may reduce Alzheimer's disease plaque and tangle pathology in the brain

Medical researchers have used a 3D human neural cell culture model to show that the exercise-induced muscle hormone, irisin, reduces the level of amyloid beta deposits associated with Alzheimer's disease.

Specialized T cells in the brain slow progression of Alzheimer's disease

Scientists found that a subset of CD8+ T cells in the brain lessens the activation of microglia and limits disease pathology in a model of Alzheimer's disease.

Phase I clinical trial shows treatment designed to clear senescent cells in Alzheimer's disease is safe

Scientists are reporting results from a Phase I trial in an area of promising research for Alzheimer's disease -- cellular senescence.

How sleep deprivation can harm the brain

Not only does a lack of sleep make you feel awful, research has shown it impairs the brain. What's more, sleep loss over long periods can even increase risk for Alzheimer's and other neurological diseases. Researchers want to understand how sleep deprivation causes this harm. In a new study, a team ...
Read More